See also this year's filing and all EDGAR filings for this company.
PDF Report 0001583107_2024_Theravance_Biopharma_Inc.pdf
Logs
Graph
Absolute values for 0001583107, Theravance Biopharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 133,541,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 9,068,000 |
| 3 | remainder_Assets | 239,390,000 |
| 4 | LiabilitiesCurrent | 24,767,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 70,866,786 |
| 9 | ResearchAndDevelopmentExpense | 38,694,512 |
| 10 | remainder_Expenses | 13,207,201 |
| 11 | remainder_Revenues | 56,812,828 |
| 12 | remainder_NetIncome | 966,024,101 |
| 13 | remainder_ComprehensiveNetIncome | -41,252 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 381,999,000 |
| 1 | Liabilities | 24,767,000 |
| 2 | Expenses | 122,768,499 |
| 3 | Revenues | 56,812,828 |
| 4 | StockholdersEquity | 357,232,000 |
| 5 | NetIncome | 900,068,430 |
| 6 | ComprehensiveNetIncome | 900,047,804 |
| 7 | BaseVar | 776,206,340 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 8.25 |
| 9 | EconomicCapitalRatio | 8.26 |
Edgar->Model Mapping
Feature Distribution
Change over Time
